Srikanth Katla

Srikanth Katla is an experienced scientific professional currently serving as an Associate Scientific Manager and Principal Scientist II at Perfect Day since March 2020, focusing on fermentation and process development. Prior to this role, Srikanth completed a Ph.D. at the Indian Institute of Technology, Guwahati, from July 2012 to December 2019, where research centered on the development of novel human interferon-alpha 2b through N-glycoengineering. Additional experience includes a Master Thesis Project at Indian Immunologicals Limited, where work involved expression, medium optimization, and fermentation studies for a recombinant epsilon toxin vaccine. Educational qualifications include a Doctor of Philosophy in Biosciences and Bioengineering, a Master of Technology in Biotechnology, and a Bachelor of Technology in Biotechnology.